Male Breast Cancer Completed Phase 2 Trials for Romidepsin (DB06176)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00098397FR901228 in Treating Patients With Metastatic Breast CancerTreatment